Neocrosin Soft Capsule (Clonixin Lysine Salt)

Adult dose

Adults: Administer 125∼250 mg of clonixin lysinate orally 3 times daily.

Individuals who regularly consume more than three alcoholic beverages per day should consult a doctor or pharmacist before taking this medication, as taking it can cause gastrointestinal bleeding in such individuals. This medication may affect the cardiovascular system and increase the risk of severe thrombotic reactions such as myocardial infarction or stroke. Those with cardiovascular diseases or risk factors should exercise greater caution and closely monitor cardiovascular symptoms during treatment. This medication can cause severe adverse reactions such as gastrointestinal bleeding, ulcers, and perforation; therefore, individuals with a history of gastrointestinal diseases or the elderly should be particularly careful. The risks may increase with prolonged use, so immediate medical evaluation and treatment are necessary if symptoms appear. Patients with peptic ulcer, those allergic to this medication or its components, and individuals who have had allergic reactions to aspirin or other non-steroidal anti-inflammatory drugs should not take this medication. Pregnant women or women who may become pregnant and patients with severe liver, kidney, or heart diseases should also refrain from using this medication. Combining this medication with other non-steroidal anti-inflammatory drugs, ACE inhibitors, aspirin, diuretics, lithium, methotrexate, anticoagulants, certain immunosuppressants, antiplatelet agents, corticosteroids, etc., can increase the risk of side effects; hence, it should not be taken together or should be done with caution. Individuals with a history of peptic ulcers, hypertension, heart failure, asthma, or liver and kidney diseases should consult with healthcare professionals before taking this medication. This medication may be secreted in breast milk, so careful consideration should be given to whether to take the medication or discontinue breastfeeding if nursing. If symptoms such as nausea, vomiting, abdominal pain, bleeding, rash, anemia, abnormal liver function, drowsiness, headache, etc., occur during use, the medication should be discontinued immediately and consultation with a healthcare professional should be sought. This medication should be used at the minimum effective dose and for the shortest duration necessary, and for those with chronic diseases, regular blood tests and liver and kidney function tests are required. It is used as symptomatic treatment to relieve inflammation and pain, and should be used with caution in conjunction with antimicrobial agents when treating infectious inflammation. Patients with hypertension or heart failure should closely monitor their blood pressure and fluid status when taking this medication and consider the risk of kidney damage with long-term use. This medication may rarely cause serious allergic reactions such as anaphylaxis or significant skin reactions, so if symptoms arise, use should be discontinued immediately. Women using this medication for a long time may have a temporary risk of infertility, so consultations with healthcare professionals are recommended if necessary. Keep this medication out of reach of children and do not transfer it to another container for safety.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, gastrointestinal or intestinal bleeding, ulcers, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, peptic ulcer, shock, rash, itching, anemia, elevated AST, elevated ALT, drowsiness, headache, dizziness, cold sweat, chills, euphoric state, jaundice, fulminant hepatitis, liver necrosis, liver failure, anemia, skin rash, exfoliative dermatitis, mucocutaneous syndrome, toxic epidermal necrolysis, severe bronchospasm

Drug interactions

Do not take this medication with non-steroidal anti-inflammatory drugs (NSAIDs), ACE inhibitors or angiotensin II receptor antagonists, aspirin, diuretics, lithium, methotrexate, coumarin anticoagulants (such as warfarin), cyclosporine and tacrolimus, antiplatelet agents, and selective serotonin reuptake inhibitors (SSRIs), or corticosteroids. Patients taking misoprostol should consult a doctor before use.

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture, and is safely stored at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and prevents degradation.

Appearance

A transparent blue oval soft capsule containing a transparent light yellow liquid

Package unit

10 capsules/PTP